Does a Hospital Fit the Practical Selection Algorithm for High-Risk Prostate Cancer Radical Prostatectomy?
For a man with high-risk prostate cancer planning radical prostatectomy, the selection algorithm is based on patient factors, not hospital characteristics—specifically: life expectancy >10 years, cN0 disease status, and understanding that RP is part of potential multimodal therapy. 1
Patient Selection Criteria for Radical Prostatectomy in High-Risk Disease
The 2024 EAU guidelines provide clear direction for offering radical prostatectomy in high-risk localized prostate cancer 1:
Primary Selection Factors:
- Life expectancy: Must exceed 10 years
- Nodal status: Should have cN0 disease (no clinical evidence of lymph node involvement)
- Treatment context: Patient must understand RP is offered "as part of potential multimodal therapy" (strong recommendation) 1
Critical Surgical Considerations:
Extended pelvic lymph node dissection (ePLND) should be performed in patients undergoing lymph node dissection (strong recommendation) 1. The decision to perform PLND should use nomogram-based risk assessment, with discussion of the patient's calculated risk of positive nodes balanced against staging benefits and complication risks 2.
If suspicious nodes are encountered intraoperatively, complete the radical prostatectomy rather than aborting the procedure (moderate recommendation) 2. Do not perform frozen section analysis to decide whether to proceed with or abandon the procedure (strong recommendation) 1.
Risk Stratification Within High-Risk Disease:
Not all high-risk prostate cancer is equivalent. Contemporary data demonstrate significant heterogeneity in outcomes 3:
Unfavorable high-risk: Biopsy primary Gleason pattern 5 and/or multiple (≥2) high-risk criteria present
- 5-year biochemical recurrence-free survival: 18.75%
Favorable high-risk: All other high-risk patients
- 5-year biochemical recurrence-free survival: 56.35%
This stratification matters for counseling and treatment planning 3.
Hospital vs. Patient Selection
The question conflates hospital selection with patient selection. The algorithm focuses entirely on patient characteristics—not hospital capabilities. However, implicit requirements exist:
Minimum Hospital Capabilities Required:
- Ability to perform extended pelvic lymph node dissection
- Access to multimodal therapy (adjuvant/salvage radiation, long-term ADT)
- Capability for nerve-sparing surgery when appropriate based on extraprostatic extension risk 4, 5
Postoperative Management Considerations:
For patients with positive lymph nodes identified at RP and undetectable postoperative PSA, either adjuvant therapy or observation may be offered (conditional recommendation) 2. Risk stratification based on pathologic variables and postoperative PSA guides this decision 2.
For pN0 patients with ISUP grade group 4-5 and pT3 ± positive margins after RP, offer adjuvant IMRT/VMAT plus IGRT (strong recommendation) 1.
Common Pitfalls to Avoid:
Do not exclude patients based solely on high-risk designation—favorable high-risk patients have reasonable outcomes with RP 3
Do not perform RP in isolation—patients must understand and accept potential need for adjuvant therapy 1
Do not skip ePLND in appropriate candidates—the staging benefit outweighs the modest increase in complications 1, 2
Do not abort surgery for positive nodes—completion of RP provides better outcomes than ADT alone 2
The algorithm is patient-centered, not hospital-centered, though the hospital must possess capabilities for comprehensive high-risk prostate cancer management including multimodal therapy options.